European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.74% to 1,491.35 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biotech firm Evaxion (EVAX), which climbed 28% and 3.5%, respectively. They were followed by biopharmaceutical company Grifols (GRFS) and internet browser company Opera (OPRA), which increased 2.7% and 2.6%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and brewing company Anheuser-Busch InBev (BUD), which fell 2.5% and 1.3%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and consumer goods company Unilever (UL), which were off 0.8% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and pharmaceutical company Silence Therapeutics (SLN), which rose 4.6% and 3.8%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and oil and gas company BP (BP), which were up 2.9% and 2.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Trinity Biotech (TRIB), which lost 2.6% and 1.9%, respectively. They were followed by tobacco company British American Tobacco (BTI) and biopharmaceutical company Verona Pharma (VRNA), which were down 1.6% and 1.5%, respectively.